Methyl 2,6-dichloro-4-(trifluoromethyl)nicotinate, 98%, 250mg

5-(Piperazin-1-yl)-1,6-naphthyridine trihydrochloride, 90.0%, 5g

2,2-Dimethylhexanoic acid, 98.0%, 250mg

2-(2-bromoethyl)-1-methylpiperidine hydrobromide, 95.0%, 250mg

3-Bromo-6-methoxypyridazine, 95.0%, 25g

2-(4-Chloro-3,5-dimethylphenoxy)propanohydrazide, 95.0%, 5g

(2R,3S)-3-Phenylisoserine hydrochloride, 95.0%, 25g

4-(3,4-Dihydropyrido[4,3-b]-1,6-naphthyridin-2(1H)-yl)-4-oxobutanoic acid, 95.0%, 1g

tert-Butyl N-(3-[(3-aminopropyl)(methyl)amino]propyl)carbamate, 95%, 100mg

Molybdic acid, min. 85%, pa, ACS, 250 g, plastic packaging.

6-METHYL-2-OXO-4-(TRIFLUOROMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBONITRILE, 95%, 10g

O-tert-Butyl-L-serine Methyl Ester Hydrochloride>98.0%(T)5g

2-amino-1-(2-chloro-4-fluorophenyl)ethan-1-one hydrochloride, 95.0%, 250mg